详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates

60| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

单位： [1]Hepatobiliary Surgery Department, Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Guangxi Medical University Cancer Hospital, Nanning, China. [2]Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [3]Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong. [4]Hepatobiliary Surgery and Transplant Unit, Azienda Ospedaliero-Universitaria di Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy. [5]Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. [6]Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China. [7]Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. [8]Department of Hepatobiliary Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. [9]Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China. [10]Department of Hepatobiliary Surgery, The First People's Hospital of Nanning, Nanning, China.

出处：

DOI：

ISSN：

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 1 区

医学

小类 | 1 区药学 1 区胃肠肝病学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区药学 2 区胃肠肝病学

JCR分区：

出版当年[2021]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY Q1 PHARMACOLOGY & PHARMACY

最新[2023]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY Q1 PHARMACOLOGY & PHARMACY

影响因子： 6.6 最新[2023版] 7.4 最新五年平均 9.524 出版当年[2021版] 9.148 出版当年五年平均 8.171 出版前一年[2020版] 7.6 出版后一年[2022版]

第一作者：

第一作者单位： [1]Hepatobiliary Surgery Department, Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Guangxi Medical University Cancer Hospital, Nanning, China.

通讯作者：

通讯机构： [1]Hepatobiliary Surgery Department, Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Guangxi Medical University Cancer Hospital, Nanning, China. [*1]Guangxi Medical University Cancer Hospital, Nanning, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：